Lifestyle

A healthy diet and lifestyle intervention utilizing daily text messages may help improve the behaviors of patients with chronic kidney disease, according to results of a pilot intervention that were presented at the virtual National Kidney Foundation Spring Clinical Meetings.

Patients who adhered to guideline-recommended medical therapy, lifestyle changes and risk factor control after an acute MI had improved long-term survival, according to a study published in the Journal of the American Heart Association.

Addressing modifiable risks through lifestyle management is crucial for primary and secondary prevention of atrial fibrillation, according to a scientific statement from the American Heart Association.

Some patients who initiated statin or antihypertensive medications made unfavorable lifestyle changes such as gaining weight and participating in less physical activity, according to a study published in the Journal of the American Heart Association.

Today is World Cancer Day.

Self-reported loneliness or living alone at the time of hospital discharge was found to be a predictor of cardiac events in men and all-cause mortality in both men and women, according to findings published in BMJ Heart.

Weight change across adulthood, even weight loss in later life, may increase an individual’s risk for all-cause and CV-related mortality, according to a study published in BMJ.

CHICAGO — Intensive lifestyle interventions and metformin therapy have had significant success in treating type 2 diabetes and should both be considered when deciding on prevention and treatment, according to a presentation at the Cardiometabolic Health Congress.

Now people may have another reason to love their dogs even more: Dog ownership was linked to improved outcomes after a major CV event and with a lower risk for death in the long term, according to two studies published in Circulation: Cardiovascular Quality and Outcomes.

The FDA today issued a series of recommendations following an advisory panel meeting on a signal of late mortality risk associated with paclitaxel-coated devices to treat peripheral artery disease, including advising clinicians to discuss extensively with patients the risks and benefits of the devices and to ensure patients are on optimal medical therapy and are following appropriate lifestyle practices.